SUMMARY The aim of the study was to examine the changes in left ventricular (LV) relaxation rate induced by variations in inotropic state. Eight normal subjects and 29 patients with coronary artery disease (CAD) were studied. First, we used interventions that increase myocardial calcium influx (atrial pacing or postpacing beat) or decrease it (intracoronary injection of nifedipine). Relaxation calcium-antagonist injections, in normal subjects and in CAD patients. We have observed that the coupling between contraction and relaxation depends on the type of inotropic stimulation. In addition, this coupling in normal subjects was different from that in CAD patients. These results are consistent with the previously proposed hypothesis'7' 22-25 that the calcium influxefflux mechanisms might play a key role in the myocardial relaxation process. They also suggest that the ventricular diastolic properties may be modified with minimal changes in systolic function.
MYOCARDIAL RELAXATION, the active process by which ventricular muscle returns to its initial length and tension,' has been extensively studied in isolated muscle'4 and in animal experiments.6f4 Clear evidence of an abnormal left ventricular relaxation in cardiac patients has been reported, particularly in coronary patients (both during angina and at rest) and in patients with hypertrophic or congestive cardiomyopathy.10-21 According to the more recent studies, some clinical manifestations, such as increased ventricular filling pressures, might partially result from these alterations in relaxation. '7-'9 Several investigators have suggested that specific therapeutic approaches, including nifedipine in hypertrophic cardiomyopathy and salbutamol in congestive cardiomyopathy, might improve these alterations in diastolic properties and contribute to the clinical improvement of the patients. '6' 17, 19 However, little is known about the possibility of altering relaxation rate independently of the inotropic state. This problem could be particularly important if relaxation had to be modified in patients with normal or depressed ventricular function.
Therefore, we further analyzed these alterations in left ventricular relaxation observed in coronary artery disease (CAD). To separate the contraction and relax-calcium-antagonist injections, in normal subjects and in CAD patients.
We have observed that the coupling between contraction and relaxation depends on the type of inotropic stimulation. In addition, this coupling in normal subjects was different from that in CAD patients. These results are consistent with the previously proposed hypothesis'7' 22-25 that the calcium influxefflux mechanisms might play a key role in the myocardial relaxation process. They also suggest that the ventricular diastolic properties may be modified with minimal changes in systolic function.
Material and Methods
Thirty-seven patients were included in this study. All were in sinus rhythm, and those with hypertension or valvular disease were excluded. All had typical or atypical angina pectoris and the hemodynamic study was performed for diagnostic purposes. Significant CAD, defined as stenosis of 75% or greater of at least one major coronary vessel, was shown in 29 patients (mean age 51.5 years, range 33-61 years), all of whom had typical angina. Eight patients (mean age 45.4 years, range 40-50 years) with completely normal coronary arteries and left ventriculography were considered as normal subjects. Clinical and angiographic data are presented in table 1. All cardioactive drugs were discontinued at least 72 hours before the procedure. In most cases the delay was 1 week. Each patient gave informed consent and no complication resulted from this study.
Left-heart catheterization was performed using the femoral approach with the patient in the fasting state and without premedication. High-fidelity left ventricular pressures were recorded at low (0-160 mm Hg) and high (0-40 mm Hg) gains with a #5F or #6F micromanometer-tip catheter (Millar Instruments). The micromanometer system was calibrated elec-tronically against a mercury manometer before inserthat has a linear response up to 60 Hz. Aortic or left tion and again after withdrawal. 57   80  71  61  81  31  21  55  15  72  85  55   76  77  86  50  64  77  77  48  71  69  70  73  47  58  74  57  52 Two experimental protocols were used. In protocol I, we attempted to produce identical changes in peak positive dP/dt in normal subjects and in CAD patients and we compared the changes in relaxation rate induced in both groups. We used interventions that increased calcium influx (atrial pacing below anginal threshold, postpacing beat) or decreased it (intracoronary nifedipine).2B-30 Protocol II, performed only in CAD patients, was designed to examine the direct role of the calcium ions in producing the changes in relaxation rate observed during the first part of the study. For that purpose, the inotropic stimulations used in protocol I were repeated after i.v. calcium administration.
Experimental Protocol I
This experimental protocol ( fig. 1 A) was performed in eight normal subjects and in 11 CAD patients (table  1) . Hemodynamic data (heart rate, systolic and diastolic aortic pressures, left ventricular systolic and end-diastolic pressures, peak positive and negative dP/dt) were first measured under basal conditions, before and after the introduction of the coronary catheter in the left main coronary artery. These hemodynamic measurements were recorded simultaneously during two or three respiratory cycles on a multichannel recording system (Honeywell 1858) at a paper speed of 200 mm/sec. Then atrial pacing was started following the protocol shown in figure LA.
When a steady state was achieved at an average heart rate of 135 beats/min, a 0.1-mg bolus of nifedipine was injected into the left main coronary artery and the pacing was continued for 3 minutes. The dose of 0.1 mg of nifedipine was used because a previous study had shown that it produced insignificant systemic effects and that its cardiac effects were limited to the first minute after injection.21
The data were recorded between the fourth and fifth minutes of pacing and 30 seconds and 3 minutes after nifedipine injection. The first postpacing beat was also analyzed (fig. IA).
Experimental Protocol II
The second protocol (fig. 1B) was performed in 18 CAD patients. This group underwent left-heart catheterization as described above and a #7F Cournand catheter was inserted into the pulmonary artery for drug injection.
Control data were recorded twice under basal conditions 5 minutes apart. Calcium injections (bolus of 2 ml of 10% calcium gluconate, i.e., 0.45 mEq of calcium) were made into the pulmonary artery, first under basal conditions and again after 4 minutes of atrial pacing at 121 beats/min ( fig. 1B ). This dose of calcium was used after preliminary studies because it produced significant positive inotropic effects with insignificant changes in left ventricular peak systolic pressure, left ventricular end-diastolic pressure (LVEDP) or heart rate and without any other side effects. Pacing was stopped 2 minutes after injection, when the positive inotropic effect of calcium was still demonstrated by an increase in peak positive dP/dt above the preinjection level; the first postpacing beat was also recorded.
No patient experienced angina pectoris or chest discomfort during the protocols. The absence of any major myocardial ischemia during pacing was also confirmed by the lack of changes in LVEDP or peak negative dP/dt after the pacings.10'
Measurements and Computations
In each recording, the cardiac cycle with the highest LVEDP (measured at the peak of the R wave) was selected for analysis. This procedure ensured that the beat was selected in expiratory phase and prevented artifactual changes in the time course of left ventricular pressure fall due to variations in intrathoracic pressures. LVEDP values obtained in this fashion are higher than those obtained by averaging LVEDP over the entire respiratory cycle.
Left ventricular pressure was digitized every 3 msec (21 13E HP computer) and the time course of its fall Under basal conditions, no significant differences were observed between normal subjects and CAD patients with respect to heart rate, LVEDP, left ven. Figure 2 illustrates the changes in T1 and peak positive dP/dt observed between control and pacing of protocol I. Despite similar increases in peak positive dP/dt, T1 decreased significantly more in CAD (16.8 ± 6.7 msec) than in the normal subjects (6.5 ± 2.9 msec; p < 0.01). Consequently, the significant difference present at rest between T1 in normal subjects and in CAD patients tended to disappear during atrial pacing. Figure 3 is a summary of the effects of intracoronary nifedipine during pacing. Again, peak positive dP/dt changes were similar in both groups, but T1 increased more in normal subjects than in CAD patients.
The changes in T1 and peak positive dP/dt during the postpacing beat are illustrated in figure 4. In the normal subjects, these values increased the T1 values, while in CAD patients, T1 decreased in all but two patients, and the difference between groups was significant despite identical increases in peak positive dP/dt (1085 vs 1057 mm Hg/sec; NS). In contrast, when the postpacing beat was obtained after calcium injection (protocol II), peak positive dP/dt again increased by 1060 mm Hg/sec, but the T1 values increased as in the normal subjects.
Discussion
The present study showed that, in man, a positive inotropic stimulus can either accelerate or slow down the speed of relaxation. Our data also indicated that the changes in left ventricular relaxation rate induced by several inotropic interventions (such as increased heart rate, postpacing beat or calcium antagonist injection) significantly differed between CAD patients and normal subjects.
Effects of Inotropic Interventions on the Relationship Between Contraction and Relaxation
The aim of the study was to compare the coupling between contraction and relaxation in normal subjects and in CAD patients. The changes in inotropic state were estimated from the changes in peak positive dP/dt. Indeed, maximum dP/dt is very responsive to (ATTJ and peak positive dP/dt (A peak + dP/dt) induced by nifedipine injection during atrial pacing compared with control conditions. Despite similar changes in peak positive dP/dt, T1 was more prolonged in normal subjects than in patients with coronary artery disease (CAD).
changes in the inotropic state and is relatively insensitive to changes in preload and afterload.33'
& In addition, changes in LVEDP were similar during all maneuvers in both groups. This suggests that our comparisons of the changes in peak positive dP/dt between groups is valid. However, a change in ventricular compliance could result from the changes in relaxation rate,'7 19 so we cannot assume that the changes in ventricular volume during pacing were exactly the same in both groups despite the comparable changes in LVEDP.
The changes in relaxation were estimated from the T, variations. However, relaxation of cardiac muscle is load-dependent,6 so before making our comparisons we had to eliminate changes in relaxation rate caused by changes in systolic pressure. The maximal rate of pressure fall is altered by these changes, and it is also likely that the whole time course of isovolumic pressure fall is affected by changes in systolic pressure,6 although this is still controversial.7 Nevertheless, in our study, such changes in systolic pressure were insignificant except during nifedipine injection (tables 2 and 3) . During injection of nifedipine, systolic pressure decreased, which should reduce T1 instead of increasing it, as we observed. Therefore, the changes in relaxation rate observed during our interventions probably were not primarily caused by changes in the loading conditions. Using these indexes, peak positive dP/dt and T,, a variable coupling between the contraction and relaxation phases was observed in three interventions. First, during pacing, inotropic state and relaxation rate increased both in normal subjects and CAD patients ( fig. 2) . Second, when nifedipine was injected during pacing, the inotropic state reverted to control levels but the relaxation was markedly prolonged (fig. 3) . Third, during the postpacing beat, the inotropic state increased but the relaxation rate was prolonged in normal subjects and slightly decreased in CAD patients (fig. 4) . This contraction-relaxation coupling was quantitatively different in normal subjects and in CAD patients (figs. 2-4).
A variable coupling was also observed in CAD patients during calcium injections which always increased inotropic state but, at the dose used in this study, accelerated relaxation only when pacing was associated (table 3) . Calcium injection also suppressed the slight decrease in T, previously observed in CAD patients during the postpacing beat ( fig. 4) .
Clinical Implications
Clinical manifestations of congestive heart failure might partially result from an alteration in the relaxation process of the ventricle11' 15-17. 19, 24 and several therapeutic interventions might improve the impaired relaxation and the patient's functional symptoms.16 ' 17, 19 Thus, the clinical relevance of our study is twofold. First, a prolonged relaxation can be observed in man despite a depressed, normal or even enhanced inotropic state.21 Further, the coupling between contraction and relaxation is abnormal in CAD. Thus, a therapeutic intervention aimed at relaxation should be cautiously adopted in each case. A calcium antagonist might improve relaxation in some types of heart disease19 but have deleterious except during the postpacing beat in normal subjects. In this situation, we observed a 5-msec T1 increase, a result very similar to the 4-msec increase previously reported in man during postextrasystolic potentiation.2S This discrepancy between the inotropic state and the relaxation rate implies that the rate of myoplasmic calcium decrease was not constant during our maneuvers. Parmley and Sonnenblick reported similar conclusions2 from the changes in relaxation observed in cat papillary muscle during positive inotropic stimulations by catecholamines, paired stimulation or changes in calcium concentration. They proposed that such a discrepancy in contractionrelaxation coupling could be due to changes in the calcium gradient between myofilaments and sarcoplasmic reticulum. 1 2 Another hypothesis might be that the rate of myoplasmic calcium decrease would be controlled by the calcium influx, following a relation of sigmoid shape ( fig. 5 ). This hypothesis could also explain the differences observed in CAD patients (figs. 2-4), provided that a slightly depressed calcium influx was postulated under basal conditions in this chronic disease. Indeed, such a small decrease in calcium influx ( fig. 5 ) would depress the relaxation under basal conditions, allow proportionally greater improvement in relaxation rate during pacing in CAD patients than in normal subjects, and allow proportionally smaller prolongation in relaxation by nifedipine. The postulated reduction in calcium influx in CAD patients at rest might be related either to the depletion in myocardial catecholamines demonstrated in these patients36 or to a change in membrane permeability as recently suggested in atherosclerotic rabbits.37 A depletion in catecholamines would indeed decrease calcium influx by depressing the gating mechanism which controls calcium entry during the action potential. 29 In conclusion, the discrepancies between contraction and relaxation described in isolated preparations1' 2 also exist in man. The study of left ventricular relaxation might provide information regarding the biochemical alterations in chronic CAD or cardiomyopathy.
